Cargando…

Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts

BACKGROUND: Antigen recognition of allo-peptides and HLA molecules leads to the activation of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated rejection (TCMR). Sequencing of the T-cell receptor (TCR) repertoire can be used to track the donor-reactive repertoire...

Descripción completa

Detalles Bibliográficos
Autores principales: Aschauer, Constantin, Jelencsics, Kira, Hu, Karin, Heinzel, Andreas, Gregorich, Mariella Gloria, Vetter, Julia, Schaller, Susanne, Winkler, Stephan M., Weinberger, Johannes, Pimenov, Lisabeth, Gualdoni, Guido A., Eder, Michael, Kainz, Alexander, Troescher, Anna Regina, Regele, Heinz, Reindl-Schwaighofer, Roman, Wekerle, Thomas, Huppa, Johannes Bernhard, Sykes, Megan, Oberbauer, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552542/
https://www.ncbi.nlm.nih.gov/pubmed/34721420
http://dx.doi.org/10.3389/fimmu.2021.750005
_version_ 1784591396135501824
author Aschauer, Constantin
Jelencsics, Kira
Hu, Karin
Heinzel, Andreas
Gregorich, Mariella Gloria
Vetter, Julia
Schaller, Susanne
Winkler, Stephan M.
Weinberger, Johannes
Pimenov, Lisabeth
Gualdoni, Guido A.
Eder, Michael
Kainz, Alexander
Troescher, Anna Regina
Regele, Heinz
Reindl-Schwaighofer, Roman
Wekerle, Thomas
Huppa, Johannes Bernhard
Sykes, Megan
Oberbauer, Rainer
author_facet Aschauer, Constantin
Jelencsics, Kira
Hu, Karin
Heinzel, Andreas
Gregorich, Mariella Gloria
Vetter, Julia
Schaller, Susanne
Winkler, Stephan M.
Weinberger, Johannes
Pimenov, Lisabeth
Gualdoni, Guido A.
Eder, Michael
Kainz, Alexander
Troescher, Anna Regina
Regele, Heinz
Reindl-Schwaighofer, Roman
Wekerle, Thomas
Huppa, Johannes Bernhard
Sykes, Megan
Oberbauer, Rainer
author_sort Aschauer, Constantin
collection PubMed
description BACKGROUND: Antigen recognition of allo-peptides and HLA molecules leads to the activation of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated rejection (TCMR). Sequencing of the T-cell receptor (TCR) repertoire can be used to track the donor-reactive repertoire in blood and tissue of patients after kidney transplantation. METHODS/DESIGN: In this prospective cohort study, 117 non-sensitized kidney transplant recipients with anti-CD25 induction were included. Peripheral mononuclear cells (PBMCs) were sampled pre-transplant and at the time of protocol or indication biopsies together with graft tissue. Next-generation sequencing (NGS) of the CDR3 region of the TCRbeta chain was performed after donor stimulation in mixed lymphocyte reactions to define the donor-reactive TCR repertoire. Blood and tissue of six patients experiencing a TCMR and six patients without rejection on protocol biopsies were interrogated for these TCRs. To elucidate common features of T-cell clonotypes, a network analysis of the TCR repertoires was performed. RESULTS: After transplantation, the frequency of circulating donor-reactive CD4 T-cells increased significantly from 0.86 ± 0.40% to 2.06 ± 0.40% of all CD4 cells (p < 0.001, mean dif.: -1.197, CI: -1.802, -0.593). The number of circulating donor-reactive CD4 clonotypes increased from 0.72 ± 0.33% to 1.89 ± 0.33% (p < 0.001, mean dif.: -1.168, CI: -1.724, -0.612). No difference in the percentage of donor-reactive T-cells in the circulation at transplant biopsy was found between subjects experiencing a TCMR and the control group [p = 0.64 (CD4(+)), p = 0.52 (CD8(+))]. Graft-infiltrating T-cells showed an up to six-fold increase of donor-reactive T-cell clonotypes compared to the blood at the same time (3.7 vs. 0.6% and 2.4 vs. 1.5%), but the infiltrating TCR repertoire was not reflected by the composition of the circulating TCR repertoire despite some overlap. Network analysis showed a distinct segregation of the donor-reactive repertoire with higher modularity than the overall TCR repertoire in the blood. These findings indicate an unchoreographed process of diverse T-cell clones directed against numerous non-self antigens found in the allograft. CONCLUSION: Donor-reactive T-cells are enriched in the kidney allograft during a TCMR episode, and dominant tissue clones are also found in the blood. TRIAL REGISTRATION: Clinicaltrials.gov: NCT: 03422224 (https://clinicaltrials.gov/ct2/show/NCT03422224).
format Online
Article
Text
id pubmed-8552542
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85525422021-10-29 Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts Aschauer, Constantin Jelencsics, Kira Hu, Karin Heinzel, Andreas Gregorich, Mariella Gloria Vetter, Julia Schaller, Susanne Winkler, Stephan M. Weinberger, Johannes Pimenov, Lisabeth Gualdoni, Guido A. Eder, Michael Kainz, Alexander Troescher, Anna Regina Regele, Heinz Reindl-Schwaighofer, Roman Wekerle, Thomas Huppa, Johannes Bernhard Sykes, Megan Oberbauer, Rainer Front Immunol Immunology BACKGROUND: Antigen recognition of allo-peptides and HLA molecules leads to the activation of donor-reactive T-cells following transplantation, potentially causing T-cell-mediated rejection (TCMR). Sequencing of the T-cell receptor (TCR) repertoire can be used to track the donor-reactive repertoire in blood and tissue of patients after kidney transplantation. METHODS/DESIGN: In this prospective cohort study, 117 non-sensitized kidney transplant recipients with anti-CD25 induction were included. Peripheral mononuclear cells (PBMCs) were sampled pre-transplant and at the time of protocol or indication biopsies together with graft tissue. Next-generation sequencing (NGS) of the CDR3 region of the TCRbeta chain was performed after donor stimulation in mixed lymphocyte reactions to define the donor-reactive TCR repertoire. Blood and tissue of six patients experiencing a TCMR and six patients without rejection on protocol biopsies were interrogated for these TCRs. To elucidate common features of T-cell clonotypes, a network analysis of the TCR repertoires was performed. RESULTS: After transplantation, the frequency of circulating donor-reactive CD4 T-cells increased significantly from 0.86 ± 0.40% to 2.06 ± 0.40% of all CD4 cells (p < 0.001, mean dif.: -1.197, CI: -1.802, -0.593). The number of circulating donor-reactive CD4 clonotypes increased from 0.72 ± 0.33% to 1.89 ± 0.33% (p < 0.001, mean dif.: -1.168, CI: -1.724, -0.612). No difference in the percentage of donor-reactive T-cells in the circulation at transplant biopsy was found between subjects experiencing a TCMR and the control group [p = 0.64 (CD4(+)), p = 0.52 (CD8(+))]. Graft-infiltrating T-cells showed an up to six-fold increase of donor-reactive T-cell clonotypes compared to the blood at the same time (3.7 vs. 0.6% and 2.4 vs. 1.5%), but the infiltrating TCR repertoire was not reflected by the composition of the circulating TCR repertoire despite some overlap. Network analysis showed a distinct segregation of the donor-reactive repertoire with higher modularity than the overall TCR repertoire in the blood. These findings indicate an unchoreographed process of diverse T-cell clones directed against numerous non-self antigens found in the allograft. CONCLUSION: Donor-reactive T-cells are enriched in the kidney allograft during a TCMR episode, and dominant tissue clones are also found in the blood. TRIAL REGISTRATION: Clinicaltrials.gov: NCT: 03422224 (https://clinicaltrials.gov/ct2/show/NCT03422224). Frontiers Media S.A. 2021-10-14 /pmc/articles/PMC8552542/ /pubmed/34721420 http://dx.doi.org/10.3389/fimmu.2021.750005 Text en Copyright © 2021 Aschauer, Jelencsics, Hu, Heinzel, Gregorich, Vetter, Schaller, Winkler, Weinberger, Pimenov, Gualdoni, Eder, Kainz, Troescher, Regele, Reindl-Schwaighofer, Wekerle, Huppa, Sykes and Oberbauer https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Aschauer, Constantin
Jelencsics, Kira
Hu, Karin
Heinzel, Andreas
Gregorich, Mariella Gloria
Vetter, Julia
Schaller, Susanne
Winkler, Stephan M.
Weinberger, Johannes
Pimenov, Lisabeth
Gualdoni, Guido A.
Eder, Michael
Kainz, Alexander
Troescher, Anna Regina
Regele, Heinz
Reindl-Schwaighofer, Roman
Wekerle, Thomas
Huppa, Johannes Bernhard
Sykes, Megan
Oberbauer, Rainer
Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
title Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
title_full Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
title_fullStr Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
title_full_unstemmed Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
title_short Prospective Tracking of Donor-Reactive T-Cell Clones in the Circulation and Rejecting Human Kidney Allografts
title_sort prospective tracking of donor-reactive t-cell clones in the circulation and rejecting human kidney allografts
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552542/
https://www.ncbi.nlm.nih.gov/pubmed/34721420
http://dx.doi.org/10.3389/fimmu.2021.750005
work_keys_str_mv AT aschauerconstantin prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT jelencsicskira prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT hukarin prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT heinzelandreas prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT gregorichmariellagloria prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT vetterjulia prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT schallersusanne prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT winklerstephanm prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT weinbergerjohannes prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT pimenovlisabeth prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT gualdoniguidoa prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT edermichael prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT kainzalexander prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT troescherannaregina prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT regeleheinz prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT reindlschwaighoferroman prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT wekerlethomas prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT huppajohannesbernhard prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT sykesmegan prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts
AT oberbauerrainer prospectivetrackingofdonorreactivetcellclonesinthecirculationandrejectinghumankidneyallografts